arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Janux Therapeutics, Inc.

JANX

$15.85 ▼ -0.26 (-1.61%) at close

26 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Janux Therapeutics, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $993.3M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -2.9% ↗

FCF / Share $-0.20

Trailing P/E —

Price / Book 1.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.73M

↓ -62.7% —

Net Income Profit after all expenses

$-24.36M

↓ -3.6% —

Operating Margin Operating profit as % of sales

-352.5%

↓ -126.9% —

FCF / Share Free cash flow per share

$-0.20

↑ +28.5% —

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	2177.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+27124%)	N/M	N/M	—	-82.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1132%)	741.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9172%)	-38.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-586%)	—	38.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+385%)	-55.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-791%)	28.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+261%)	—	56.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+605%)	390.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4783%)	318.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3877%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-2.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-45.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	23.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-400.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-26.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-45.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-104.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	73.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	38.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	-34.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-3.6% Weak ↑ Weak Improving Year-over-year change in net income	-58.0% Weak ↑ Weak Improving Year-over-year change in net income	13.4% Fair ↑ Fair Improving Year-over-year change in net income	-468.2% Weak ↓ Weak Declining Year-over-year change in net income	-59.3% Weak ↓ Weak Declining Year-over-year change in net income	-71.9% Weak ↓ Weak Declining Year-over-year change in net income	-142.6% Weak ↓ Weak Declining Year-over-year change in net income	66.0% Excellent ↑ Excellent Improving Year-over-year change in net income	15.5% Good ↓ Good Declining Year-over-year change in net income	26.8% Excellent ↑ Excellent Improving Year-over-year change in net income	30.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-3.7% Weak ↑ Weak Improving Year-over-year change in net income	-30.2% Weak ↑ Weak Improving Year-over-year change in net income	-19.7% Weak ↑ Weak Improving Year-over-year change in net income	-55.1% Weak ↑ Weak Improving Year-over-year change in net income	-172.1% Weak ↑ Weak Improving Year-over-year change in net income	-487.1% Weak ↑ Weak Improving Year-over-year change in net income	-710.6% Weak ↓ Weak Declining Year-over-year change in net income	-757.2% Weak Weak Year-over-year change in net income	-152.3% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	28.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	8.2% Fair Fair Year-over-year change in free cash flow	—	—	—	9.8% Fair Fair Year-over-year change in free cash flow	—	—	—	99.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	22.2% Excellent Excellent Compound annual revenue growth over 3 years	—	76.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	-27.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	164.3% Excellent Excellent Compound annual revenue growth over 3 years	48.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	57.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	-352.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2450%)	—	—	—	—	-155.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1136%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-243.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2126%)	—	—	—	—	-67.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-658%)	—	—	-459.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3930%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-337.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-129.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-2.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-2.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.8% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	8.9% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	7.4% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-3.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-4.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-4.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-10.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-2.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-2.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	-2.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	-2.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	-4.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-106%)	-2.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	-3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	-3.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-5.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-5.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-4.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-3.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-3.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-2.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	-1.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	13.6% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	11.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-25%)	9.6% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-36%)	20.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+39%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-51.83M	$-52.33M	$-48.39M	$-52.45M	$-73.74M	$-430.61M	$-26.75M	$-14.66M	$-212.80M	—	$-17.15M	$-33.70M	$-30.36M	—	$-64.75M	$-58.40M	$-55.13M	$-35.58M	$-39.39M	$-251.62M	—	$-7.81M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.06	—	$0.16	$0.00	$0.00	—	$0.01	$0.16	$0.03	—	$0.06	$0.03	$0.05	—	$0.04	$0.06	$5.16	—	$2.43	$0.82	$1.25	—	$0.00	$0.00	—	—
Basic EPS, GAAP (USD)	$-0.39	$-0.51	$-0.39	$-0.55	$-0.38	$-0.35	$-0.51	$-0.11	$-0.30	$-0.24	$-0.25	$-0.42	$-0.42	$-0.39	$-0.40	$-0.41	—	$-0.29	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.20	—	$-0.21	$-0.39	$-0.28	—	—	—	$-0.31	—	—	—	$-0.34	—	—	—	$-40.59	—	—	—	$17.78	—	$-5.34	—	—	—
Book Value per Share (USD)	$15.47	$15.85	$16.24	$16.70	$17.11	$17.32	$12.54	$12.61	$12.65	—	$7.56	$7.15	$7.45	—	$7.98	$8.28	$8.60	$8.88	$9.15	$9.36	$-55.11	$-13.99	$-64.33	$-46.24	—	—
Tangible Book Value per Share (USD)	$15.47	$15.85	$16.24	$16.70	$17.11	$17.32	$12.54	$12.61	$12.65	—	$7.56	$7.15	$7.45	—	$7.98	$8.28	$8.60	$8.88	$9.15	$9.36	$-55.11	$-13.99	$-64.33	$-46.24	—	—
Basic Weighted Avg Shares (shares)	62.67M	—	62.02M	61.90M	61.79M	—	54.63M	54.45M	49.05M	—	45.71M	41.84M	41.76M	—	41.53M	41.45M	307,765	—	477,408	589,054	304,303	—	202,655	255,373	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$943.13M	$950.89M	$970.25M	$984.17M	$1.01B	$1.02B	$649.15M	$650.39M	$648.06M	—	$340.72M	$291.40M	$305.29M	—	$328.00M	$345.07M	$352.14M	$364.22M	$377.12M	$387.40M	—	$12.88M	—	—	—	—
Total Equity (USD)	$941.53M	$956.82M	$976.55M	$990.52M	$1.01B	$1.02B	$656.10M	$657.68M	$655.76M	$344.35M	$348.95M	$299.47M	$311.26M	$320.74M	$331.51M	$343.81M	$356.08M	$366.33M	$376.75M	$384.80M	$-16.77M	$-14.64M	$-13.04M	$-11.81M	$-9.35M	$-7.94M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$3.73M	—	$10.00M	$0.00	$0.00	—	$439.00K	$8.90M	$1.25M	—	$2.52M	$1.06M	$2.05M	—	$1.81M	$2.37M	$1.59M	—	$1.16M	$482.00K	$380.00K	—	$0.00	$0.00	—	—
Depreciation Expense (USD)	$469.00K	$468.00K	$501.00K	$541.00K	$519.00K	$512.00K	—	—	$532.00K	$531.00K	—	—	$453.00K	$403.00K	—	—	$81.00K	$64.00K	—	—	$9.00K	$9.00K	$1.00K	—	—	—
Net Income, GAAP (USD)	$-24.36M	$-31.95M	$-24.31M	$-33.86M	$-23.51M	$-20.22M	$-28.06M	$-5.96M	$-14.76M	$-11.76M	$-11.57M	$-17.51M	$-17.46M	$-16.07M	$-16.70M	$-16.89M	$-13.41M	$-13.42M	$-10.77M	$-6.21M	$-2.28M	$-1.66M	$-1.26M	$-2.46M	—	—
Operating Cash Flow (USD)	$-12.34M	$-28.54M	$-12.86M	$-23.81M	$-17.02M	$-16.73M	—	—	$-14.84M	$-9.90M	—	—	$-13.91M	$-11.91M	—	—	$-11.52M	$-10.48M	—	—	$5.56M	$-1.63M	$-1.08M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Janux Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare JANX with peers